Investor Relations Investor Center Stock Information Financial Information Corporate Governance Press Releases Events & Presentations Investor FAQ Contact Us
SEC Filing Details Document Details Form 4 Filing Date Feb 3, 2023 Document Date Feb 1, 2023 Form Description Statement of changes in beneficial ownership of securities Filing Group 3,4,5 Company Arbutus Biopharma Corporation Issuer ARBUTUS BIOPHARMA CORP Filer HASTINGS DAVID C Filing Formats View HTML Download PDF Download DOC Download XLS Shareholder Tools Email Alerts Email Alerts RSS News Feeds RSS News Feeds Download Library Download Library
SEC Filing Details Document Details Form 4 Filing Date Feb 3, 2023 Document Date Feb 1, 2023 Form Description Statement of changes in beneficial ownership of securities Filing Group 3,4,5 Company Arbutus Biopharma Corporation Issuer ARBUTUS BIOPHARMA CORP Filer HASTINGS DAVID C Filing Formats View HTML Download PDF Download DOC Download XLS Shareholder Tools Email Alerts Email Alerts RSS News Feeds RSS News Feeds Download Library Download Library